The primary outcome measure of the study is:
Change in weekly average of daily pain scores (patient pain diary)
70 patients were given placebo
70 patients were given Z160
Analysis of this data can be done in a single day because there is no clinical imaging or other technical test results to deal with.
This data is all patient pain diary based.
Results could come before or on October, 7th 2013 with no problem.
THIS IS SIMPLE!
Sentiment: Strong Buy
The captain knows! He did make mention of phase III start next year.
Was this during Zalicus Inc at Rodman & Renshaw Global Investment Conference 09/09/13 at 10:25 a.m. ET?
What time in the talk (min/sec)?